Indian state drug regulator orders sample checks on all oral liquid solutions: Report

Published: Updated:
Enable Read mode
100% Font Size

The drug regulator of India’s Maharashtra state has ordered sample checks on all oral liquid solutions in the state, asking for reports on the levels of diethylene glycol and ethylene glycol, CNBC TV18 reported on Thursday.

The regulator’s direction comes a day after Indian health authorities said they had halted all production of New Delhi-based Maiden Pharmaceuticals following a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.

For the latest headlines, follow our Google News channel online or via the app.

The WHO said last week that laboratory analysis of four Maiden products - Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup - had “unacceptable” amounts of diethylene glycol and ethylene glycol, which can be toxic and lead to acute kidney injury.

Gambian police, in a preliminary investigation report on Tuesday, said that the deaths of 69 children from acute kidney injury was linked to the cough syrups made in India and imported via a US-based company.

Read more: UAE doctors warn of health risks linked to sugar-free soda, sweeten

Top Content Trending